UOC
MDXG icon

UBS O'Connor’s MiMedx Group MDXG Stock Holding History

UBS O'Connor’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-45,000
Closed -$319K – 505
2014
Q2 		$319K Sell
45,000
-55,000
-55% -$322K ﹤0.01% 379
2014
Q1 		$613K Buy
+100,000
New +$735K 0.01% 351

Other funds holding MDXG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS O'Connor's MDXG Position: Q3 2014 in Review

UBS O'Connor sold out of MiMedx Group (MDXG) in Q3 2014, closing a stake of 45,000 shares — an estimated $319K sold.

UBS O'Connor first reported a position in MDXG in Q1 2014 and held it in 2 quarters. The position peaked at $613K in Q1 2014. 125 funds tracked by Wall St. Rank hold MDXG as of Q3 2014.

  • UBS O'Connor reported no remaining MiMedx Group position as of Q3 2014 after selling out during the quarter.
  • UBS O'Connor sold 45,000 MiMedx Group shares in Q3 2014, an estimated $319K.
  • UBS O'Connor first reported a position in MiMedx Group in Q1 2014 and held it in 2 quarters.
  • UBS O'Connor's MiMedx Group position peaked at $613K in Q1 2014.
  • 125 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2014.

Based on UBS O'Connor's 13F filing for Q3 2014, filed 14 Nov 2014.